NovelStem International Corp. (NSTM)

0.0095 0.00 (0.00%) USD  |  OTCM  |  Sep 04, 16:00
More

NovelStem International SG&A Expense (TTM) : 0.1201M for June 30, 2026

SG&A Expense (TTM) Chart

View SG&A Expense (TTM) for NSTM.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View SG&A Expense (TTM) Chart
Start Trial

Historical SG&A Expense (TTM) Data

View and export this data back to 1998. Start Trial.
Date Value
June 30, 2026 0.1201M
March 31, 2026 0.1491M
December 31, 2025 0.2388M
September 30, 2025 0.198M
June 30, 2025 0.7251M
March 31, 2025 0.8052M
December 31, 2024 0.8939M
September 30, 2024 0.9238M
June 30, 2024 0.4415M
March 31, 2024 0.6838M
December 31, 2023 0.6653M
September 30, 2023 1.004M
June 30, 2023 1.050M
March 31, 2023 1.271M
December 31, 2022 1.990M
September 30, 2022 2.376M
December 31, 2013 3.186M
September 30, 2013 3.594M
June 30, 2013 3.350M
March 31, 2013 3.291M
December 31, 2012 2.992M
September 30, 2012 3.219M
June 30, 2012 4.643M
March 31, 2012 5.549M
December 31, 2011 7.224M
Date Value
September 30, 2011 7.655M
June 30, 2011 11.43M
March 31, 2011 15.50M
December 31, 2010 15.70M
September 30, 2010 14.03M
June 30, 2010 10.64M
March 31, 2010 7.409M
December 31, 2009 10.16M
September 30, 2009 10.16M
June 30, 2009 10.85M
March 31, 2009 12.52M
December 31, 2008 11.70M
September 30, 2008 11.70M
June 30, 2008 16.68M
March 31, 2008 20.98M
December 31, 2007 25.12M
September 30, 2007 33.73M
June 30, 2007 33.08M
March 31, 2007 32.11M
December 31, 2006 31.86M
September 30, 2006 30.63M
June 30, 2006 30.01M
March 31, 2006 30.01M
December 31, 2005 28.68M
September 30, 2005 29.46M

SG&A Expense (TTM) Range, Past 5 Years

View SG&A Expense (TTM) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

SG&A Expense (TTM) Benchmarks

View SG&A Expense (TTM) Benchmarks
Start Trial
Brainstorm Cell Therapeutics, Inc. 6.474M
Summit Therapeutics, Inc. 306.10M
Kezar Life Sciences, Inc. 18.27M
Protara Therapeutics, Inc. 23.56M
Clene, Inc. 7.873M